Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Pfizer sells ViiV stake to Shionogi

South Africa Time — Tuesday, January 20, 2026

The 11.7% economic interest in specialist HIV company ViiV Healthcare that is currently held by US pharma giant Pfizer is to be replaced with an ...

View article...

Racial Xperience

Top stories of the last 30 days

Top 10 counties in new HIV infections

South Africa Time — Monday, December 29, 2025

In 2024, Kenya witnessed a concerning rise in new HIV infections, with the total number increasing by 19% from 16752 cases in 2023 to 19991. View article...

U.S. needs to reinstate lifesaving programs for HIV

South Africa Time — Monday, December 29, 2025

Many of us know someone who experienced the misery of untreated HIV : wasting, fevers, skin covered with lesions, blindness, pneumocystis, ... View article...

Global health workers strengthen US security

South Africa Time — Monday, December 29, 2025

... HIV , tuberculosis and maternal health services across Africa. They talked about navigating informal settlements to reach patients who missed ... View article...

This Castro clinic was on the front lines of HIV care. After 60 years, it's still changing lives

South Africa Time — Monday, December 29, 2025

Back in the 1990s, Stafford Hemmer would visit San Francisco's Castro-Mission Health Center near his home every three months or so for an HIV test. View article...

From survival to longevity: What aging with HIV looks like in 2025

South Africa Time — Tuesday, December 30, 2025

Learn about the medical advancements and challenges faced by older adults living with HIV . Experts and survivors share their insights. View article...

Ministry approves long-acting HIV prevention drug for rollout

South Africa Time — Monday, January 12, 2026

The injection is given once every six months and prevents HIV infection even in unprotected sex. View article...

Meet to strengthen NGOs' role in HIV prevention

South Africa Time — Monday, December 29, 2025

Meet to strengthen NGOs' role in HIV prevention. Event was chaired ... HIV /AIDS prevention, treatment and care services. Special emphasis was ... View article...

Barriers experienced by patients in adhering to antiretroviral treatment in a mobile clinic ...

South Africa Time — Monday, December 29, 2025

Antiretroviral treatment (ART) plays a significant role in the wellbeing of individuals living with human immunodeficiency virus ( HIV ) and ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B

South Africa Time — Tuesday, January 20, 2026

In 2024, GSK reported sales of its HIV treatments at 7.1 billion pounds sterling ($9.1 billion), trailing its primary rival in the market, Gilead ... View article...

The near death -- and last-minute reprieve -- of a trial for an HIV vaccine

South Africa Time — Tuesday, January 20, 2026

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would ... View article...

ViiV ownership shifts as Pfizer sells its stake

South Africa Time — Tuesday, January 20, 2026

Under the terms of the deal, GSK retains its majority position in ViiV, with a 78.3% stake, while Shionogi's share more than ... View article...

Adolescents report a preference for long-acting injectable HIV therapy

South Africa Time — Tuesday, January 20, 2026

Adolescents with HIV reported strong preference, viral suppression, and favorable safety outcomes after switching to long-acting injectable ... View article...

An Assault on Vaccine Science and Policy, and the Stakes for Global Health

South Africa Time — Tuesday, January 20, 2026

Undermining the research infrastructure now risks slowing progress for years to come—for HIV , other STIs and infectious diseases, pandemic ... View article...

Iraq blames overseas travel and tattoos for rise in HIV cases

South Africa Time — Tuesday, January 20, 2026

Iraq has recorded a slight rise in HIV cases, with health officials warning that overseas travel and unregulated tattooing are key risk factors. View article...

Pharma jumps 6% after receiving order for supply of Azithromycin 500 mg tablets

South Africa Time — Tuesday, January 20, 2026

This is a formulation manufacturing company with a focus on anti-infective, BetaLactums, cephalosporin, antimalarial, antiretroviral , ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews